Lincoln Pharma introduces ear spray for tinnitus cure

22 Jan 2013 Evaluate

Lincoln Pharmaceuticals (LPL) has launched Tinnex ear spray to cure the ringing problem by signing pact with Phafag AG, Switzerland, for its Caroverine molecule for the treatment of tinnitus. Tinnitus commonly known as ringing in the ear is a condition where the inner hair cells get damaged causing continuous depression, anxiety and insomnia in patients.

The Ahmedabad-based company became the first company in India to introduce a cure for tinnitus with the launch of the Tinnex injection, spray and capsule.

Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc.

Lincoln Pharma Share Price

567.65 -15.40 (-2.64%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...